The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)

ADHD Predominantly Inattentive Type Clinical Trial

Official title:
The Effect of Methylphenidate (Ritalin IR) Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the familial response to Methylphenidate treatment (Ritalin IR) in two aspects: ADHD symptom's improvement and side-effects development.

Clinical Trial Description

Attention Deficit/Hyperactivity Disorder (ADHD) is very prevalent and tends to continue from childhood to adult life. It's heritability is 76%. It was found that there is a greater ADHD prevalence in first-degree families of ADHD subjects- 4-6 times more than the general population. Pharmacological treatment is the first line treatment today in ADHD, in children and adults, and Methylphenidate (specially Ritalin IR) is the first medication given for the disorder. The study includes couples of first-degree family members, both diagnosed with ADHD. Subjects will receive Ritalin IR for 4 weeks and undergo several psychiatric and cognitive questionnaires at each time of the follow-up meeting (a total of 3). ;

Study Design

Related Conditions & MeSH terms

ADHD Predominantly Hyperactivity Type
ADHD Predominantly Inattentive Type
ADHD-not Other Specified
Attention Deficit Disorder with Hyperactivity
Attention Deficit/Hyperactivity Disorder Combined Type
Hyperkinesis

Clinical Trial Details

NCT number	NCT01554046
Study type	Interventional
Source	Sheba Medical Center
Contact
Status	Completed
Phase	N/A
Start date	October 2011
Completion date	April 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03190902` - Cognitive Impairment in Pediatric Onset Multiple Sclerosis	N/A
Active, not recruiting	`NCT04090983` - Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation	N/A
Not yet recruiting	`NCT06081348` - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders	Phase 2
Completed	`NCT05452954` - Psychosocial ADHD Interventions - Brief Parent Training	N/A
Recruiting	`NCT04504890` - Ocular-vestibular Biomarker Identification for ADHD
Recruiting	`NCT06299189` - A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care	N/A
Recruiting	`NCT04729439` - Technology-Enhanced Executive Functioning Intervention for ADHD	Phase 1
Completed	`NCT01685281` - Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder	Phase 2